Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peggy Scherle currently holds 230,000 shares of Prelude Therapeutics Inc (PRLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peggy Scherle has been a net seller of PRLD stock. They have purchased $0 and sold $2.3M worth of shares.
Peggy Scherle's most recent insider trade was on Feb 4, 2026, when they sold 230,000 shares at $0.00 per share.
Peggy Scherle serves as Executive at Prelude Therapeutics Inc (PRLD). They have executed 27 insider transactions totaling $2.3M over their tenure at the company.
Peggy Scherle holds the position of Executive at Prelude Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Peggy Scherle has shown a selling trading pattern, with $0 in total purchases and $2.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peggy Scherle was on Jul 27, 2021, when they sold $684.9K worth of PRLD shares. This transaction involved 19,320 shares at $35.45 per share.
Peggy Scherle currently owns 230,000 shares of Prelude Therapeutics Inc (PRLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peggy Scherle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peggy Scherle has 27 Form 4 filings on record as an insider at Prelude Therapeutics Inc.
Set alerts for Peggy Scherle and 40,000+ other insiders.